| Literature DB >> 33238340 |
Irena Sakura Rini1, Alberta Jesslyn Gunardi1, Renate Parlene Marsaulina1, Teguh Aryandono2, Ishandono Dachlan3, Iwan Dwiprahasto4.
Abstract
The keystone design perforator island flap can be utilized in the repair of trunk defects. A systematic review was carried out to identify the complication rates of the use of this flap to treat such defects. The MEDLINE, Embase, Cochrane Library, and PubMed Central databases were searched for articles published between January 2003 and December 2018 that reported the use of keystone design perforator island flaps in the repair of trunk defects. Study selection was conducted in alignment with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Eight articles involving a total of 54 flaps satisfied the inclusion criteria. The most frequently reported cause of trunk defects was oncologic resection (64.4%). The overall complication rate was 35.2%, and complications included infection (11.1%), wound dehiscence (7.4%), delayed healing (7.4%), and partial flap loss (1.9%). The keystone design perforator island flap is associated with a high success rate and low technical complexity. Despite minor complications, keystone design flaps could be a preferred choice for trunk reconstruction.Entities:
Keywords: Perforator flap; Reconstructive surgical procedures; Systematic review; Torso
Year: 2020 PMID: 33238340 PMCID: PMC7700866 DOI: 10.5999/aps.2020.00094
Source DB: PubMed Journal: Arch Plast Surg ISSN: 2234-6163
Fig. 1.Traditional classification of the keystone flap
(A) Skin island flap for defects of up to 2 cm. (B) Division of deep fascia and skin graft for repair of a secondary defect. (C) Double keystone flap (D) undermined up to 50% of the flap subfascially. Adapted from Behan. ANZ J Surg 2003;73:112-20, with permission John Wiley and Sons [1].
Fig. 2.Omega variant design of keystone flap
Synthesis of data from case studies and case series
| Author (year) | Level of evidence | No. of cases | No. of flaps | Mean age of defect (yr) | Follow-up duration (mon) | Complication rate and types |
|---|---|---|---|---|---|---|
| Pelissier et al. (2007) [ | 4 | 2 | 2 | 31.5 | 4 | No significant complications |
| Khouri et al. (2011) [ | 4 | 9 | 9 | Not described | Not described | 33.3% (n = 3): partial flap loss (n = 1), dehiscence (n = 2) |
| Stone et al. (2015) [ | 4 | 3 | 3 | 63.7 | Not described | 66.7% (n = 2): dehiscence (n = 1), delayed healing (n = 1) |
| Park et al. (2016) [ | 4 | 5 | 5 | 1.4 day | Not described | No significant complications |
| Mohan et al. (2016) [ | 4 | 6 | 6 | 64.5 | 1 | 83.3% (n = 5): wound complication (n = 1), delayed healing (n = 3), seroma (n = 1), hematoma (n = 1), dehiscence (n = 1) |
| Lanni et al. (2017) [ | 4 | 20 | 20 | Not described | Not described | 25% (n = 5): wound complication (n = 1), infection (n = 2), hypertrophic scar (n = 1), contour deformity (n = 1) |
| Park et al. (2018) [ | 4 | 3 | 3 | 27 | Not described | 66.7% (n = 2): infection (n = 2) |
| Donaldson et al. (2018) [ | 4 | 6 | 6 | 1.67 day | 4–94 | 33.3% (n = 2): infection (n = 2) |
Fig. 3.Flowchart of article identification and inclusion
Fig. 4.Causes of defects
Fig. 5.Oncologic causes of defects
Fig. 6.Types and frequencies of complications